A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive or Refractory CNS Tumors

Trial Profile

A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive or Refractory CNS Tumors

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs Pomalidomide (Primary)
  • Indications CNS cancer; Nervous system neoplasms
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
    • 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 19 Jul 2016 Status changed from suspended to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top